[{"Assets_0_Q2_USD":251230000.0,"CommonStockSharesOutstanding_0_Q2_shares":20709797.0,"EarningsPerShareBasic_1_Q2_USD":0.4,"EarningsPerShareBasic_2_Q2_USD":0.69,"EarningsPerShareDiluted_1_Q2_USD":0.38,"EarningsPerShareDiluted_2_Q2_USD":0.66,"NetIncomeLoss_1_Q2_USD":8338000.0,"NetIncomeLoss_2_Q2_USD":14270000.0,"StockholdersEquity_0_Q2_USD":207777000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":21848359.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":21731592.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":20622320.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":20556293.0,"Ticker":"INGN","CIK":"1294133","name":"INOGEN INC","OfficialName":"Inogen Inc Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640231286.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]